Asymmetric Synthesis and Biological Evaluation of Both Enantiomers of 5- and 6-Boronotryptophan as Potential Boron Delivery Agents for Boron Neutron Capture Therapy

This research investigates boronated tryptophans as potential boron delivery agents for boron neutron capture therapy (BNCT) of cancer. We synthesized both enantiomers of 5- and 6-boronotryptophans (<b>1a</b> and <b>1b</b>) using simple and inexpensive methods. Their uptake was assessed in two human cancer cell lines, CAL27 (head and neck cancer) and U87-MG (brain cancer), and compared to l-<i>p</i>-boronophenylalanine (l-BPA) as a reference. To determine whether these tryptophan derivatives are substrates for large amino acid transporter 1, we performed molecular dynamics simulations to explore their transport mechanism. Our findings reveal differences in boron compound accumulation between the cancer cell lines, indicating that tryptophan derivatives could serve as effective boron carriers when the clinically used boron carrier, BPA, is ineffective.

Authors

Institutions

Publication Details

Journal
ACS Medicinal Chemistry Letters
Published
2024-11-11
DOI
https://doi.org/10.1021/acsmedchemlett.4c00241
Citations
3
Primary Topic
Boron Compounds in Chemistry
Type
article
Field-Weighted Citation Impact
1.21

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Asymmetric Synthesis and Biological Evaluation of Both Enantiomers of 5- and 6-Boronotryptophan as Potential Boron Delivery Agents for Boron Neutron Capture Therapy

Kristiina M. Huttunen, Henna Pehkonen, Michele Retini, Francesca Bartoccini et al.
3 citations
ACS Medicinal Chemistry Letters
Boron Compounds in Chemistry
1.21
article

Asymmetric Synthesis and Biological Evaluation of Both Enantiomers of 5- and 6-Boronotryptophan as Potential Boron Delivery Agents for Boron Neutron Capture Therapy

Kristiina M. Huttunen, Henna Pehkonen, Michele Retini, Francesca Bartoccini, Juri M. Timonen, Jarkko Rautio, Katayun Bahrami, Tuomo Laitinen, Giovanni Piersanti, Janne Tampio, Juulia Järvinen, Petri Riihelä, Arina Värä
article en
3 citations

Abstract

This research investigates boronated tryptophans as potential boron delivery agents for boron neutron capture therapy (BNCT) of cancer. We synthesized both enantiomers of 5- and 6-boronotryptophans (<b>1a</b> and <b>1b</b>) using simple and inexpensive methods. Their uptake was assessed in two human cancer cell lines, CAL27 (head and neck cancer) and U87-MG (brain cancer), and compared to l-<i>p</i>-boronophenylalanine (l-BPA) as a reference. To determine whether these tryptophan derivatives are substrates for large amino acid transporter 1, we performed molecular dynamics simulations to explore their transport mechanism. Our findings reveal differences in boron compound accumulation between the cancer cell lines, indicating that tryptophan derivatives could serve as effective boron carriers when the clinically used boron carrier, BPA, is ineffective.

ACS Medicinal Chemistry LettersVol. 15(12)
University of Helsinki (FI), University of Eastern Finland (FI), University of Urbino (IT)
European Commission, Academy of Finland, Suomen Kulttuurirahasto, Päivikki ja Sakari Sohlbergin Säätiö, China Scholarship Council, Università degli Studi di Urbino Carlo Bo, Biocenter Finland, Suomalainen Konkordia-liitto, Ministero dell'Università e della Ricerca, European Social Fund
Openalex Percentile: Top 19%
Boron Compounds in Chemistry
1.21
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.